ABL oncogene amplification with p16INK4a gene deletion in precursor T-cell acute lymphoblastic leukemia/lymphoma: Report of the first case

American Journal of Hematology

Volumn 76, Issue 4, 2004, Pages 360-363

  Kim, Hee Jin ^a   Woo, Hee Yeon ^a   Koo, Hong Hoe ^a   Tak, Eun Young ^a   Kim, Sun Hee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

ABL; Acute lymphoblastic leukemia; Deletion; Gene amplification; p16INK4a

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CASE REPORT; CHILD; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHRONIC MYELOID LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE DELETION; GENE TRANSLOCATION; HETEROZYGOSITY; HUMAN; LEUKEMOGENESIS; LYMPHOBLASTOMA; MALE; ONCOGENE; P16 INK4A GENE; PRIORITY JOURNAL; PROTO ONCOGENE; STEM CELL; T LYMPHOCYTE; TUMOR SUPPRESSOR GENE;

CHILD; CHROMOSOMES, HUMAN, PAIR 9; GENE AMPLIFICATION; GENE DELETION; GENES, ABL; GENES, P16; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, T-CELL, ACUTE; MALE;

EID: 3342994970     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20117     Document Type: Article

References (17)

1. Brown DD, Dawid IB. Specific gene amplification in oocytes. Oocyte nuclei contain extrachromosomal replicas of the genes for ribosomal RNA. Science 1968;160:272-280.
2. Pauletti G, Dandekar S, Rong H, et al. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 2000;18:3651-3664.
3. Vogel CL, Cobleigh MA, Tripathy D, et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 2002;20:719-726.
4. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-1037.
5. Hochhaus A, Kreil S, Corbin AS, et al. Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy. Leukemia 2002;16:2190-2196.
6. Okuda T, Shurtleff SA, Valentine MB, et al. Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood 1995;85:2321-2330.
7. Calero Moreno TM, Gustafsson G, Garwicz S, et al. Deletion of the Ink4-locus (the pl6ink4a, pI4ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92. Leukemia 2002;16:2037-2045.
8. Nordgren A, Heyman M, Sahlen S, et al. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases. Eur J Haematol 2002;68:31-41.
9. Tanaka K, Arif M, Eguchi M, Kyo T, Dohy H, Kamada N. Frequent jumping translocations of chromosomal segments involving the ABL oncogene alone or in combination with CD3-MLL genes in secondary leukemias. Blood 1997;89:596-600.
10. Kenner L, Beham-Schmid C, Kerbl R, Schmidt HH, Sill H, Hoefler G. ABL amplification in a patient with lymphoid blast crisis of chronic myelogenous leukaemia. Virchows Arch 1999;434:255-257.
11. Schwab M. Oncogene amplification in solid tumors. Semin Cancer Biol 1999;9:319-325.
12. Le Coniat M, Romana SP, Berger R. Partial chromosome 21 amplification in a child with acute lymphoblastic leukemia. Genes Chromosomes Cancer 1995;14:204-209.
13. Fugazza G, Bruzzone R, Puppo L, Patrone F, Sessarego M, Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. Leuk Res 1997;21:703-709.
14. Avet-Loiseau H, Godon C, Li JY, et al. Amplification of the 11q23 region in acute myeloid leukemia. Genes Chromosomes Cancer 1999;26:166-170.
15. Kirn HJ, Cho HI, Kim EC, et al. A study on 289 consecutive Korean patients with acute leukaemias revealed fluorescence in situ hybridization detects the MLL translocation without cytogenetic evidence both initially and during follow-up. Br J Haematol 2002;119:930-939.
16. Busson-Le Coniat M, Nguyen Khac F, Daniel MT, Bernard OA, Berger R. Chromosome 21 abnormalities with AML1 amplification in acute lymphoblastic leukemia. Genes Chromosomes Cancer 2001;32:244-249.
17. Garcia-Manero G, Jeha S, Daniel J, et al. Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia. Cancer 2003;97:695-702.